Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Aromatherapy research sits at the center of this dementia and brain health question.
Research into aromatherapy and sensory interventions for Alzheimer’s disease has produced encouraging but limited evidence suggesting that certain scents and multisensory approaches may help reduce agitation, improve mood, and enhance quality of life in some patients. While aromatherapy is not a treatment for the disease itself—it cannot slow cognitive decline or reverse the underlying neurological damage—studies indicate that lavender oil inhalation, for example, has shown measurable reductions in aggressive behaviors and restlessness in some individuals with moderate to advanced Alzheimer’s. The fundamental appeal lies in aromatherapy’s simplicity: it’s non-pharmacological, generally low-risk, and offers caregivers an additional tool in the limited arsenal available for managing behavioral and emotional symptoms.
The science here is still developing, and results vary considerably between individuals. What works profoundly for one person may have no effect on another, which makes aromatherapy most useful as a complementary strategy alongside existing medical care rather than a primary intervention. Researchers emphasize that sensory interventions work through multiple pathways—direct effects on the brain through olfactory systems, but also through creating calming environments, providing sensory engagement, and offering meaningful activities that may distract from distress.
Table of Contents
- What Does Current Research Show About Aromatherapy and Alzheimer’s Behavior?
- How Sensory Interventions Engage the Dementia Brain
- Essential Oils and Compounds Showing Promise in Research
- Delivering Aromatherapy in Home and Care Facility Settings
- Safety Considerations and Important Limitations
- Multimodal Sensory Approaches Beyond Aromatherapy
- Future Research Directions and Emerging Evidence
- Conclusion
What Does Current Research Show About Aromatherapy and Alzheimer’s Behavior?
The most robust evidence for aromatherapy in Alzheimer’s care focuses on behavioral and psychological symptoms of dementia (BPSD), which include agitation, aggression, anxiety, and sundowning. A frequently cited finding involves lemon balm (melissa) aromatherapy reducing agitation in patients with moderate to severe dementia, with some studies showing improvements in up to 60 percent of participants. Lavender essential oil has similarly demonstrated calming effects in several small trials, though the mechanism isn’t entirely clear—it may involve both the pharmacological properties of lavender compounds and the ritual and comfort of aromatherapy administration itself.
However, the quality and consistency of research varies significantly. Many studies are small, lack robust control groups, or don’t adequately distinguish between the direct effects of aromatherapy and the broader benefits of increased attention and environmental enrichment that aromatherapy use often introduces. A 2023 systematic review found that while many aromatherapy interventions showed positive effects on agitation and anxiety, the overall strength of evidence remains moderate at best, with significant heterogeneity in outcomes. This means replying results is difficult because studies use different oils, concentrations, delivery methods, and outcome measures.
How Sensory Interventions Engage the Dementia Brain
The theoretical foundation for sensory interventions in Alzheimer’s rests on understanding how the olfactory system connects directly to brain regions involved in emotion and memory, particularly the amygdala and hippocampus. In Alzheimer’s disease, many cognitive pathways degrade, but the olfactory system can sometimes remain relatively more intact, at least in earlier stages, creating a potential avenue for engagement when other communication channels fail. When a person with advanced Alzheimer’s may no longer recognize their adult child verbally, a familiar scent can sometimes trigger emotional response or a fragmented memory, bypassing the damaged cognitive networks that have lost language and conscious recall.
One significant limitation of sensory interventions is individual variability and unpredictability. A scent that grounds one person with Alzheimer’s may distress another whose scent memories are tied to trauma or loss. Additionally, olfactory perception itself can deteriorate with Alzheimer’s progression, meaning interventions that work in mid-stage disease may become ineffective as the disease advances. Caregivers sometimes report that aromatherapy that seemed helpful for weeks suddenly becomes ineffective, or that a patient who previously calmed with lavender now seems indifferent or agitated by it.
Essential Oils and Compounds Showing Promise in Research
Lavender (Lavandula angustifolia) remains the most studied oil in Alzheimer’s aromatherapy research, with multiple small trials suggesting benefits for anxiety and agitation. Its active compounds, including linalool and linalyl acetate, have demonstrated sedative and anxiolytic properties in animal models and some human studies. Lemon balm (Melissa officinalis) has shown promise for reducing agitation, and in one notable study conducted in nursing homes, patients receiving lemon balm aromatherapy showed less aggressive behavior compared to control groups over a 12-week period. Rosemary oil has gained attention for potential cognitive effects—some preliminary research suggests it may enhance alertness and cognitive function, though evidence remains anecdotal in dementia populations.
Chamomile, frankincense, and geranium have been explored in aromatherapy protocols for dementia, primarily targeting anxiety and sleep disturbance. Important to note: essential oils are concentrated plant extracts with biochemical activity, not merely pleasant smells. They can interact with medications, trigger allergic reactions, and in some cases cause respiratory or dermal irritation, particularly in elderly individuals with compromised health. Peppermint oil, for instance, can exacerbate reflux in some patients, and highly concentrated oils applied directly to skin can cause irritation.
Delivering Aromatherapy in Home and Care Facility Settings
In practical application, aromatherapy is typically delivered through diffusion (nebulizing the oil into air), inhalation (allowing the person to smell the oil directly), or topical application (diluted oil applied to skin, often to the hands or wrists). Diffusion through a standard aromatherapy diffuser is popular in care facilities because it affects the broader environment without direct handling, though it’s less targeted than direct inhalation. Some facilities use aroma patches or scent-infused textiles placed near patients’ pillows or chairs. In home settings, caregivers often use personal inhalation—placing a few drops on a cotton ball near the person, or allowing them to smell essential oil on the caregiver’s wrists during calming activities.
The tradeoff between convenience and effectiveness matters here: diffusion is easiest to implement consistently, but direct inhalation allows for individual titration and timing. A family caregiver might use aromatherapy specifically during challenging times, like late afternoon when sundowning typically occurs, whereas a facility might run a diffuser continuously in a unit. Neither approach is universally better—the choice depends on individual patient response, facility capacity, and what family dynamics allow. Documentation of when aromatherapy is used and what behavioral changes follow is important but often neglected, making it difficult to determine whether improvements are actually due to the intervention.
Safety Considerations and Important Limitations
Essential oils are not regulated as medicines in most countries, meaning quality, purity, and safety data vary dramatically between brands and sources. Some commercial products labeled as “therapeutic grade” lack scientific verification, and some contain contaminants or misrepresented ingredients. For elderly individuals, particularly those with respiratory conditions like chronic obstructive pulmonary disease (COPD) or asthma, direct inhalation of strong essential oil vapors can trigger bronchospasm or breathing difficulties. Topical application without proper dilution in carrier oils risks skin irritation, and some oils (particularly peppermint and certain citrus oils) can increase photosensitivity, a concern for older adults who may be on medications affecting skin sensitivity.
A critical limitation is that aromatherapy cannot address the underlying pathology of Alzheimer’s disease. It does not prevent or slow plaque and tangle formation, does not regenerate neurons, and cannot restore lost cognitive function. If behavioral improvements occur—which they often do—they represent symptom management, not disease modification. Additionally, overreliance on aromatherapy may delay other necessary interventions, including medication adjustment, environmental modification, or assessment for underlying pain or medical conditions driving behavioral changes. A person with Alzheimer’s who becomes increasingly agitated may be reacting to untreated urinary tract infection, constipation, or medication side effects, not to stress that aromatherapy can solve.
Multimodal Sensory Approaches Beyond Aromatherapy
The most compelling evidence for sensory interventions emerges not from aromatherapy alone, but from integrated sensory approaches that combine multiple modalities. Music therapy, for instance, has stronger evidence than aromatherapy for reducing agitation and improving emotional response in Alzheimer’s, particularly when using personally meaningful music from the person’s earlier decades. Tactile interventions—hand massage, grooming, or petting animals—show documented benefits for anxiety and agitation.
Combining aromatherapy with music, gentle touch, and meaningful activity creates a more immersive sensory environment that engages multiple pathways simultaneously. A care facility might offer a “reminiscence hour” where residents with Alzheimer’s experience era-appropriate music, look at photographs, handle textured objects, and have access to a familiar scent—all together. In this context, the aromatherapy contributes to a larger therapeutic package, and isolating its individual effect becomes nearly impossible. This multimodal approach is likely more effective than aromatherapy alone, but also requires more staff time and coordination, which may not be feasible in all settings.
Future Research Directions and Emerging Evidence
As neuroimaging and neurochemical measurement techniques improve, future research will likely clarify which specific compounds affect which brain regions and which patient subgroups show the strongest responses to aromatherapy. Preliminary work using functional MRI suggests that certain scents activate specific brain networks even in Alzheimer’s patients with significant neurodegeneration, but this research is still preliminary.
Additionally, larger randomized controlled trials with standardized aromatherapy protocols and longer follow-up periods could establish whether current observations reflect genuine therapeutic benefit or response bias. The field is also moving toward personalized approaches—attempting to identify which individuals are most likely to benefit from aromatherapy and which specific scents work best for particular patients based on their dementia stage, behavioral profile, and scent history. This individualized medicine approach is more complex to research but more realistic about how sensory interventions actually work in heterogeneous populations like those with Alzheimer’s disease.
Conclusion
Aromatherapy and sensory interventions represent a reasonable, low-risk complement to standard dementia care, particularly for managing behavioral and emotional symptoms. Current research supports cautious optimism about lavender and lemon balm for reducing agitation in some patients, and the olfactory system’s relative preservation in early-to-mid-stage Alzheimer’s offers a legitimate pathway for engagement and comfort. However, the evidence remains moderate in strength, effects are highly variable between individuals, and aromatherapy should never replace comprehensive medical assessment or necessary medication management.
For families and caregivers considering aromatherapy, the practical approach involves starting with well-researched oils like lavender, monitoring behavioral and emotional responses carefully, using properly diluted and pure-source products, and maintaining awareness of safety considerations including respiratory and dermal risks. Pairing aromatherapy with other sensory interventions—music, meaningful activity, and tactile comfort—likely offers better outcomes than aromatherapy alone. Continue working closely with the healthcare team managing the person’s Alzheimer’s care, reporting what interventions seem helpful, and remaining realistic that sensory comfort strategies, while valuable, cannot address the underlying disease progression.
You Might Also Like
- Stakeholder Engagement Forums Shape Alzheimer’s Research Priorities
- Lysosomal Function Research Connects Cellular Waste Processing to Alzheimer’s
- Generative AI Tools Accelerate Alzheimer’s Research Workflows
For more, see NIH MedlinePlus — dementia.
